History

Company history

1947

Rodolfo Ferrari and Carlo Callerio founded the Italian company SPA to produce Penicillin

1950

Collaboration between SPA and Sir Alexander Fleming to develop a large scale Penicillin and Lysozyme production company

1972

SPA established first lysozyme plant on industrial scale at NIVE Nunspeet The Netherlands

1983

SPA estabilished Fordras SA specialized in Lysozyme sales API in Japan and worldwide

1994

Canadian former Inovatech, Neova Technologies Inc. started Lysozyme and Trypsin production in the US Fordras plant . SPA develops a new systemic antifungal SPK 843

2002

Spin off of Lysozyme and SPK 843 from SPA

2008
Merger of Fordras, Neova Technologies and KD Pharma under Bioseutica BV
2011
New Shareholders structure – Group reorganisation to deal with market opportunities
2012

Bioseutica expands on new specialties like: NA2R, Ovotransferrin and Entegard

2017

Bioseutica acquires Belovo from BNL Food Group in Belgium. Development of AquaTryp